Triple
T21057657
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ocrelizumab |
E518760
|
entity |
| Predicate | effectOnImmuneSystem |
P40373
|
FINISHED |
| Object | selective depletion of CD20-expressing B cells |
—
|
LITERAL FINISHED |
Provenance (3 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69e0b5053ac48190921529544959e906 |
elicitation | completed |
| NER | batch_69e6fd81434c8190aedfddf937f82322 |
ner | completed |
| PD | batch_69e5dbf9d71881908cd85dfc37db93ca |
pd | completed |
Created at: April 16, 2026, 2:37 p.m.